Gabriela L. Martins
Belo Horizonte, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Rivaroxaban versus warfarin: differential effects on oxidative stress and fibrinolytic markers in atrial fibrillation.
Journal: Frontiers in pharmacology
Published: August 13, 2025
Evaluation of New Potential Inflammatory Markers in Patients with Nonvalvular Atrial Fibrillation.
Journal: International journal of molecular sciences
Published: November 21, 2022
Evaluation of serum haptoglobin levels and Hp1-Hp2 polymorphism in the haptoglobin gene in patients with atrial fibrillation.
Journal: Molecular biology reports
Published: February 08, 2022
Role of Oxysterols in the Activation of the NLRP3 Inflammasome as a Potential Pharmacological Approach in Alzheimer's Disease.
Journal: Current neuropharmacology
Published: December 03, 2021
Serotonin and dopamine receptors profile on peripheral immune cells from patients with temporal lobe epilepsy.
Journal: Journal of neuroimmunology
Published: September 15, 2020
Thrombin Generation and other hemostatic parameters in patients with atrial fibrillation in use of warfarin or rivaroxaban.
Journal: Journal of thrombosis and thrombolysis
Published: May 08, 2020
Comparison of Inflammatory Mediators in Patients With Atrial Fibrillation Using Warfarin or Rivaroxaban.
Journal: Frontiers in cardiovascular medicine
Published: March 25, 2020
Inflammatory and Infectious Processes Serve as Links between Atrial Fibrillation and Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: November 24, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026